Quarterly report pursuant to Section 13 or 15(d)

Sponsored Research and Clinical Trial Agreements (Tables)

v3.19.1
Sponsored Research and Clinical Trial Agreements (Tables)
 3 Months Ended
Mar. 31, 2019
Aevitas Therapeutics Inc [Member]  
Schedule Of Expense Related To Sponsered Research Arrangements For the three months ended March 31, 2019 and 2018, Aevitas recorded the following expense in research and development for sponsored research and clinical trial agreements:
 
 
 
For the Three Months Ended March 31,
 
($ in thousands)
 
2019
 
 
2018
 
UMass – AAV
 
$
–
 
 
$
100
 
UPenn – AAV
 
 
250
 
 
 
–
 
Total
 
$
250
 
 
$
100
 
Mustang Therapeutics, Inc [Member]  
Schedule Of Expense Related To Sponsered Research Arrangements
For the three months ended March 31, 2019 and 2018, Mustang recorded the following expense in research and development for sponsored research and clinical trial agreements:
 
 
 
For the Three Months Ended March 31,
 
($ in thousands)
 
2019
 
 
2018
 
City of Hope (COH)
 
$
500
 
 
$
500
 
COH – CD123 (MB-102)
 
 
303
 
 
 
150
 
COH – IL13R
a
2 (MB-101)
 
 
342
 
 
 
360
 
COH – manufacturing
 
 
114
 
 
 
114
 
Fred Hutch-CD20 (MB-106)
 
 
267
 
 
 
266
 
BIDMC – CRISPR
 
 
69
 
 
 
–
 
Total
 
$
1,595
 
 
$
1,390